Roche Holding, Ltd., a Swiss healthcare company, and Spain-based Junta de Andalucia Department of Health (JADH) have signed an agreement for a cooperation in the Medical Genome Project (MGP). MGP is a research project created to analyse the genomes of people with rare diseases and identify the defective gene or genes causing the disease and its behaviour.

Under the terms of the agreement, Roche will contribute EUR4 million to the MGP. In exchange, Roche reserves the right of first refusal over any possible license regarding discoveries made within the scope of the project.

The project, initiated by the JADH, will begin in 2010 and extend to 2013. The research will take place in the Scientific and Technical Complex Cartuja 93 (Seville) and will be lead by Prof. Shomi Bhattacharya and Dr. Guillermo Antinolo, associated director and director of the Andalusian Genetic Plan, and Dr. Joaquin Dopazo, associated director of Bioinformatics in the Andalusian Program for Genetic Research and Genomics.

In the first phase, the research project will concentrate on defining the whole variability of human genes and will work with about 300 DNA samples, each of which can contain up to 26,000 different genes. Once the genetic variability has been defined, it will be compared with the genetic alterations observed in rare diseases to identify the causal gene or genes of thousands of these conditions.

In the final phase, the project will concentrate on the search for specific therapies for genetic-based diseases in the field of personalised healthcare. The approach of personalized healthcare is to use new molecular insights and molecular diagnostic tests to better tailor medicines and better manage diseases. Roche aims at tailoring medicine as closely as possible to patients' needs.

Deal Type    Partnership
Sub-Category Research and discovery
Deal Status  Announced: 2009-11-24

Deal Participants

Partner 1 (Company) Roche Holding, Ltd.
Partner 2 (Company) Junta de Andalucia Department of Health

(c) 2001-2007 Datamonitor. All rights reserved. Republication or redistribution, including by framing or similar means, is expressly prohibited without prior written consent. Datamonitor shall not be liable for errors or delays in the content, or for any actions taken in reliance thereon.